InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Krakonos post# 191220

Saturday, 09/20/2014 5:23:21 PM

Saturday, September 20, 2014 5:23:21 PM

Post# of 345700
My bad..

Meant to say $2.5M investment

...that way even if a collaborator may lose out to a competitor, they still have an investment or vested in to try and use PS Targeting on their next drug of choice. MAybe that is a good round number..$2.5M to join the Bavi club and yearly dues there after and royalties of course with any future profits...hmmmmmm


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News